Literature DB >> 19387473

A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome.

Jonas C Löfling1, Adrienne W Paton, Nissi M Varki, James C Paton, Ajit Varki.   

Abstract

Hemolytic-uremic syndrome (HUS) is a systemic disease characterized by microvascular endothelial damage, mainly in the gastrointestinal tract and the kidneys. A major cause of HUS is Shiga toxigenic Escherichia coli (STEC) infection. In addition to Shiga toxin, additional STEC virulence factors may contribute to HUS. One is the newly discovered subtilase cytotoxin (SubAB), which is highly toxic to eukaryotic cells, and when injected intraperitoneally into mice causes pathology resembling that associated with human HUS. Recent data show that SubAB exhibits a strong preference for glycans terminating in alpha2-3-linked N-glycolylneuraminic acid (Neu5Gc), a sialic acid that humans are unable to synthesize, because we genetically lack the necessary enzyme. However, Neu5Gc can still be found on human cells due to metabolic incorporation from the diet. Dietary incorporation happens to be highest in human endothelium and to a lesser extent in the intestinal epithelium, the two affected cell types in STEC-induced HUS. Mammalian-derived foods such as red meat and dairy products appear to be the primary source of dietary Neu5Gc. Ironically, these are also common sources of STEC contamination. Taken together, these findings suggest a 'two-hit' process in the pathogenesis of human SubAB-induced disease. First, humans eat Neu5Gc-rich food, leading to incorporation of Neu5Gc on the surfaces of endothelial and intestinal cells. Second, when exposed to a SubAB-producing STEC strain, the toxin produced would be able to bind to the intestinal epithelial cells, perhaps causing acute gastrointestinal symptoms, and eventually damaging endothelial cells in other organs like the kidney, thereby causing HUS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387473      PMCID: PMC2752721          DOI: 10.1038/ki.2009.131

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

Review 1.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

2.  Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.

Authors:  A W Paton; M C Woodrow; R M Doyle; J A Lanser; J C Paton
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.

Authors:  Muriel Bardor; Dzung H Nguyen; Sandra Diaz; Ajit Varki
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

4.  A structural difference between the cell surfaces of humans and the great apes.

Authors:  E A Muchmore; S Diaz; A Varki
Journal:  Am J Phys Anthropol       Date:  1998-10       Impact factor: 2.868

5.  Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin.

Authors:  Emma Byres; Adrienne W Paton; James C Paton; Jonas C Löfling; David F Smith; Matthew C J Wilce; Ursula M Talbot; Damien C Chong; Hai Yu; Shengshu Huang; Xi Chen; Nissi M Varki; Ajit Varki; Jamie Rossjohn; Travis Beddoe
Journal:  Nature       Date:  2008-10-29       Impact factor: 49.962

6.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

Review 7.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

8.  Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid.

Authors:  Pam Tangvoranuntakul; Pascal Gagneux; Sandra Diaz; Muriel Bardor; Nissi Varki; Ajit Varki; Elaine Muchmore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

Review 9.  Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution.

Authors:  A Varki
Journal:  Am J Phys Anthropol       Date:  2001       Impact factor: 2.868

10.  A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli.

Authors:  Adrienne W Paton; Potjanee Srimanote; Ursula M Talbot; Hui Wang; James C Paton
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  13 in total

1.  Colloquium paper: uniquely human evolution of sialic acid genetics and biology.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

2.  Cytotoxic and apoptotic effects of recombinant subtilase cytotoxin variants of shiga toxin-producing Escherichia coli.

Authors:  J Funk; N Biber; M Schneider; E Hauser; S Enzenmüller; C Förtsch; H Barth; H Schmidt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Quantification of sialic acids in red meat by UPLC-FLD using indoxylsialosides as internal standards.

Authors:  Hong L Yao; Louis P Conway; Mao M Wang; Kun Huang; Li Liu; Josef Voglmeir
Journal:  Glycoconj J       Date:  2016-03-11       Impact factor: 2.916

Review 4.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.

Authors:  Kalyan Banda; Christopher J Gregg; Renee Chow; Nissi M Varki; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

Review 6.  Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome.

Authors:  Heather Kerr; Anna Richards
Journal:  Immunobiology       Date:  2011-07-30       Impact factor: 3.144

7.  N-Acetylneuraminic Acid Supplementation Prevents High Fat Diet-Induced Insulin Resistance in Rats through Transcriptional and Nontranscriptional Mechanisms.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; Norsharina Ismail; Nur Hanisah Azmi; Waiteng Wong; Hadiza Altine Adamu; Nur Diyana Md Zamri; Aini Ideris; Maizaton Atmadini Abdullah
Journal:  Biomed Res Int       Date:  2015-11-25       Impact factor: 3.411

8.  Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant.

Authors:  Joschua Funk; Helen Stoeber; Elisabeth Hauser; Herbert Schmidt
Journal:  BMC Microbiol       Date:  2013-10-15       Impact factor: 3.605

9.  N-Acetylneuraminic acid attenuates hypercoagulation on high fat diet-induced hyperlipidemic rats.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; WaiTeng Wong; Maizaton Atmadini Abdullah; Aini Ideris; Norsharina Ismail
Journal:  Food Nutr Res       Date:  2015-12-04       Impact factor: 3.894

10.  High fat diet-induced inflammation and oxidative stress are attenuated by N-acetylneuraminic acid in rats.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; Norsharina Ismail; Aini Ideris; Maizaton Atmadini Abdullah
Journal:  J Biomed Sci       Date:  2015-10-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.